Health Care Equipment & Supplies · NYSE

BDXBecton Dickinson & Co

Last close
$218.03 +1.1%
52-week range
$140.11 to $219.78
Market cap
$59.4B
Next earnings
Not scheduled

Fiscal 2025 at a glance

Revenue
$21.8B
+8% vs FY24
Net income
$1.68B
-2% vs FY24
Free cash flow
$2.67B
-14% vs FY24
Net cash
-$18.6B
Cash $567M, debt $19.2B

Stock price

+31% since Dec 2016

Valuation vs its own 10 years

Below its 10-year median on 2 of 3 multiples

Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.

P/E, trailing
65.9x
27.5x593x
74th percentile, above its median of 46.5x
Positive-earnings quarters only
Price / sales
2.6x
1.8x4.7x
13th percentile, below its median of 3.7x
EV / EBITDA
15.2x
11.6x38.0x
13th percentile, below its median of 20.0x
Price / free cash flow
n/a
n/a: Not meaningful (negative or missing)
Median 27.9x, range 20.2x to 57.6x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-06-30. Every figure carries its unit.

Valuation

P/E
65.9x
Earnings yield
1.5%
Price / sales
2.6x
Price / book
2.4x
Price / operating cash flow
n/a
EV / EBITDA
15.2x
EV / sales
3.2x
Free cash flow yield
n/a

n/a: Not reported

Profitability

Gross margin
46.9%
Operating margin
10.7%
Net margin
4.0%
Return on equity
3.9%
Return on capital
5.3%

Growth per year

Revenue, 3 years
+5.0%
Revenue, 5 years
+6.3%
Revenue, 9 years
+6.4%
EPS, 3 years
-0.3%

Balance sheet

Cash and investments
$708M
Total debt
$16.8B
Net cash
-$16.1B
Debt / equity
0.69x
Current ratio
0.87x

Shares and dividend

Shares outstanding
272M
Share count, 5 years
+2.2%
Beta, 1 year
0.29
Dividend yield
1.9%
Dividend per share, TTM
$4.19
Payout ratio
125%

Ten years of the business

Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $4.98B
RevenueNet income
Gross profitLatest quarter $2.31B
EBITDALatest quarter $1.23B
Margins46 / 13 / 8%
GrossOperatingNet
Earnings per shareLatest quarter $1.37
Cash flowLatest quarter $776M
OperatingCapexFree
Cash vs debtLatest quarter $708M
Cash and investmentsTotal debt
P/E historyNow 65.9x
P/E, median 46.5x dashed
P/S historyNow 2.6x
P/S, median 3.7x dashed

Where the revenue comes from

Asia went from 16% to 14% of revenue in 3 years

Share of revenue by region, fiscal 2022 to 2025, as reported in the 10-K.

USEMEAAsiaOthers Country
FY22
57%21%16%
$18.9B
FY23
57%22%15%
$19.4B
FY24
58%22%14%
$20.2B
FY25
59%22%14%
$21.8B
Fiscal 2025 by region
RegionRevenueSharevs FY24
US$12.8B58.6%+10%
EMEA$4.73B21.7%+7%
Asia$3.09B14.2%+6%
Others Country$1.23B5.6%+2%

Health Care Equipment & Supplies peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
ABT Abbott Laboratories $188B +10% 13.8%40.4x3.9x 60th percentile
DHR Danaher Corp $164B +6% 20.4%38.1x6.4x 65th percentile
ISRG Intuitive Surgical Inc $154B +20% 28.4%53.7x13.3x 48th percentile
MDT Medtronic plc $132B +10% 18.1%25.3x3.5x 20th percentile
SYK Stryker Corp $118B +8% 20.7%33.0x4.5x 30th percentile
BDX Becton Dickinson & Co $59.4B +17% 10.7%65.9x2.6x 74th percentile

The company

Sector
Health Care
Industry
Health Care Equipment & Supplies
Founded
1897
Headquarters
Franklin Lakes, NJ
Fiscal year ends
September
Website
bd.com

What it does

Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about BDX.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 1,142 active funds. Crowd level: quiet.

Open the Smart money tab